NCT06793059View on ClinicalTrials.gov

Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2027

Conditions
Aneurysm
Interventions
DEVICE

SHIELD

Pipeline SHIELD device under study

Trial Locations (1)

14203

Jacobs Institute, Buffalo

All Listed Sponsors
lead

Carlos Pena, PhD, MS

OTHER

NCT06793059 - Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD) | Biotech Hunter | Biotech Hunter